N4 Pharma PLC (AIM: N4P) has officially changed its name to Thalia Therapeutics plc, effective March 18, 2026.
N4 Pharma PLC (AIM: N4P) has officially changed its name to Thalia Therapeutics plc, effective March 18, 2026.
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
International Consolidated Airlines Group (IAG) has unveiled plans to return another €1.5 billion in cash to investors, as it benefited from resilient demand on its core transatlantic routes and lower fuel
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
CEO Appointment, Strategic Update and Name Change to Thalia Therapeutics
The Times: The headline rate of inflation fell more than expected in November to a 10-month low – increasing expectations that the Bank of England will cut interest rates tomorrow. The
Collaboration combines N4 Pharma’s innovative Nuvec® delivery platform with CMAC’s world-class expertise to accelerate development and broaden therapeutic applications
N4 Pharma PLC (AIM: N4P) shares surged after the company announced that its Nuvec® delivery system had successfully targeted non-small cell lung cancer cells in collaboration with leading US research
N4 Pharma plc (AIM: N4P), the biotech developing Nuvec®, its proprietary gene delivery system to enable advanced therapies for cancer and other diseases, is pleased to announce the appointment of Dr
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Audioboom, Blue
N4 Pharma CEO Q&A Now LIVE
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system designed to carry nucleotides to be developed as cancer treatments and vaccines, is delighted to